Role of Caregiver in the Clinical Pathway of Patients With Breast and Prostate Cancer
Launched by EUROPEAN INSTITUTE OF ONCOLOGY · Jun 20, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the involvement of caregivers can impact the care and support of patients newly diagnosed with breast or prostate cancer. It aims to understand the effects of providing psychological support to both patients and their caregivers right after a cancer diagnosis and before they meet with their oncologist to discuss treatment options. The goal is to see if this support can improve the emotional well-being of both the patient and their caregiver during a challenging time.
To participate in this study, patients must be at least 18 years old, have recently received a diagnosis of early-stage breast or prostate cancer, and have not yet discussed treatment with their oncologist. Caregivers must also be 18 or older and actively caring for the patient. Participants can expect to engage in a supportive program designed to help them cope with the diagnosis and navigate the upcoming discussions about treatment. This study is currently recruiting participants, so if you fit the criteria and are interested, it could be a valuable opportunity to receive additional support during this difficult journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Patient:
- • Patient aged ≥18 years at the time of recruitment.
- • Patients who have just received a cancer diagnosis and have yet to discuss with their oncologist the treatment to undergo after diagnosis of breast or prostate cancer.
- • Early-stage cancer (I or II).
- Caregiver:
- • Age ≥ 18 at the time of recruitment.
- • Taking care of the patient.
- Exclusion Criteria:
- Patients:
- • Presence of early mental disorders (before age 40) or severe neurological disorder.
- • Patients with advanced stage cancer for which the path is already defined (palliative care patients).
- Caregivers:
- • ● Presence of early mental disorders (before age 40) or severe neurological disorder.
About European Institute Of Oncology
The European Institute of Oncology (IEO) is a leading research and treatment center based in Milan, Italy, dedicated to advancing cancer care through innovative clinical research and personalized medicine. Renowned for its commitment to multidisciplinary approaches, IEO integrates cutting-edge research with clinical practice to improve patient outcomes. The institute actively sponsors and conducts clinical trials across various cancer types, fostering collaboration between oncologists, researchers, and industry partners. With a focus on translating scientific discoveries into effective therapies, IEO plays a pivotal role in the global fight against cancer, contributing to the development of new treatment protocols and enhancing the understanding of oncological diseases.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Patients applied
Trial Officials
Gabriella Pravettoni
Principal Investigator
European Institute of Oncology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported